Results 151 to 160 of about 11,960 (207)

Therapeutic efficacy and safety of artemether-lumefantrine combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria at Teda Health Centre, Northwest Ethiopia, 2022/23. [PDF]

Malar J
Woldesenbet D, Birhanie M, Abere A, Zeleke AJ, Bezabih MK, Semaw M, Wubetie M, Abebe W, Tamene E, Tegegne Y.   +9 more
europepmc   +1 more source

Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021. [PDF]

Malar J
Dorkenoo AM, Warsame M, Ataba E, Hemou M, Yakpa K, Sossou E, Mitigmsagou M, Teou CD, Caspar E, Ma L, Djadou KE, Atcha-Oubou T, Rasmussen C, Menard D.   +13 more
europepmc   +1 more source

Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda. [PDF]

PLoS One
Angwe MK, Mwebaza N, Nsobya SL, Vudriko P, Dralabu S, Omali D, Tumwebaze MA, Ocan M.   +7 more
europepmc   +1 more source

CYP2B6*6single nucleotide polymorphism among patients with uncomplicated malaria in Adjumani district, Uganda: implications on efficacy of artemether-lumefantrine

Angwe MK, Mwebaza N, Nsobya SL, Kiguba R, Vudriko P, Dralabu S, Omali D, Tumwebaze MA, Ocan M.   +8 more
europepmc   +1 more source

Co-Infectious Mystery: Why Artemether-Lumefantrine Cleared <i>P. falciparum</i> but Left <i>P. malariae</i> behind. [PDF]

Indian J Hematol Blood Transfus
Nunes D, Luís F, Flores MAQ, Ribeiro C, Vaz Carneiro C, Melo Cristino J.   +5 more
europepmc   +1 more source

Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial.

Lancet Microbe
Mahamar A, Vanheer LN, Smit MJ, Sanogo K, Sinaba Y, Niambele SM, Diallo M, Dicko OM, Diarra RS, Maguiraga SO, Youssouf A, Sacko A, Keita S, Samake S, Dembele A, Teelen K, Dicko Y, Traore SF, Dondorp A, Drakeley C, Stone W, Dicko A.   +21 more
europepmc   +1 more source

Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda

Angwe MK, Mwebaza N, Nsobya SL, Vudriko P, Dralabu S, Omali D, Tumwebaze MA, Ocan M.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Artemether-Lumefantrine: An Option for Malaria

Annals of Pharmacotherapy, 2012
Objective: To review the pharmacology, pharmacokinetics, safety, and efficacy of artemether-lumefantrine for the treatment of Plasmodium falciparum malaria. Data Sources: English-language articles indexed in PubMed (1947-November 2011)
Travis King
exaly   +3 more sources

Artemether-lumefantrine for uncomplicated malaria: a systematic review

Tropical Medicine and International Health, 2004
BACKGROUND The World Health Organization (WHO) is promoting artemether-lumefantrine for treating uncomplicated malaria. The objective of this review is to summarize available evidence of its effects compared with other antimalarial regimens.METHODS We ...
Paul Garner, Carrol Gamble
exaly   +2 more sources

Artemether/lumefantrine

Reactions Weekly, 2023
  +4 more sources